Recursion Pharmaceuticals (RXRX) Q4 2023 Earnings

27FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.45
-0.42
-0.38
-0.35

Details

Expected EPS
-0.44875
Actual EPS
-0.42
Surprise EPS
0.03
Surprise Percent
+6.41%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.42 per share for Q4 2023.

0 Comments

Share your thoughts